Home » Topics » BioWorld Science

BioWorld Science
RSS

TxA2 antagonists/TxA2 synthase inhibitors from Fujisawa

July 12, 1996

Bristol-Myers Squibb's Pravachol cleared by FDA for new indication

July 12, 1996

Teijin's prostaglandin MCP-1/MCAF inhibitors

July 12, 1996

Smooth muscle cell proliferation inhibitors described by American Home Products

July 12, 1996

NEP inhibition research findings

July 12, 1996

Endothelin antagonists part of Fujisawa's pipeline

July 12, 1996

Na+/K+-ATPase inhibitors revealed by Sigma-Tau

July 12, 1996

Icos granted U.S. patent for rPAF-AH

July 12, 1996

Torii and Hisamitsu disclose elastase inhibitors

July 12, 1996

APC-366 covered under U.S. patent

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...